These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 36973114)

  • 1. Newborn screening for spinal muscular atrophy in Osaka -challenges in a Japanese pilot study.
    Kimizu T; Ida S; Oki K; Shima M; Nishimoto S; Nakajima K; Ikeda T; Mogami Y; Yanagihara K; Matsuda K; Nishi E; Hasegawa Y; Nozaki M; Fujita H; Irie A; Katayama T; Okamoto N; Imai K; Nishio H; Suzuki Y
    Brain Dev; 2023 Aug; 45(7):363-371. PubMed ID: 36973114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiplex Real-Time PCR-Based Newborn Screening for Severe Primary Immunodeficiency and Spinal Muscular Atrophy in Osaka, Japan: Our Results after 3 Years.
    Kimizu T; Nozaki M; Okada Y; Sawada A; Morisaki M; Fujita H; Irie A; Matsuda K; Hasegawa Y; Nishi E; Okamoto N; Kawai M; Imai K; Suzuki Y; Wada K; Mitsuda N; Ida S
    Genes (Basel); 2024 Feb; 15(3):. PubMed ID: 38540372
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presymptomatic Diagnosis of Spinal Muscular Atrophy Through Newborn Screening.
    Chien YH; Chiang SC; Weng WC; Lee NC; Lin CJ; Hsieh WS; Lee WT; Jong YJ; Ko TM; Hwu WL
    J Pediatr; 2017 Nov; 190():124-129.e1. PubMed ID: 28711173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Spinal Muscular Atrophy Based on the Results of a Large-Scale Pilot Project on 202,908 Newborns.
    Efimova IY; Zinchenko RA; Marakhonov AV; Balinova NV; Mikhalchuk KA; Shchagina OA; Polyakov AV; Mudaeva DA; Saydaeva DH; Matulevich SA; Parshintseva PD; Belyashova EY; Yakubovskiy GI; Tebieva IS; Gabisova YV; Irinina NA; Jamschikova AV; Nurgalieva LR; Saifullina EV; Nevmerzhitskaya KS; Belyaeva TI; Romanova OS; Voronin SV; Kutsev SI
    Pediatr Neurol; 2024 Jul; 156():147-154. PubMed ID: 38781723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. One Year of Newborn Screening for SMA - Results of a German Pilot Project.
    Vill K; Kölbel H; Schwartz O; Blaschek A; Olgemöller B; Harms E; Burggraf S; Röschinger W; Durner J; Gläser D; Nennstiel U; Wirth B; Schara U; Jensen B; Becker M; Hohenfellner K; Müller-Felber W
    J Neuromuscul Dis; 2019; 6(4):503-515. PubMed ID: 31594245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pilot study of population-based newborn screening for spinal muscular atrophy in New York state.
    Kraszewski JN; Kay DM; Stevens CF; Koval C; Haser B; Ortiz V; Albertorio A; Cohen LL; Jain R; Andrew SP; Young SD; LaMarca NM; De Vivo DC; Caggana M; Chung WK
    Genet Med; 2018 Jun; 20(6):608-613. PubMed ID: 29758563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infants Diagnosed with Spinal Muscular Atrophy and 4 SMN2 Copies through Newborn Screening - Opportunity or Burden?
    Müller-Felber W; Vill K; Schwartz O; Gläser D; Nennstiel U; Wirth B; Burggraf S; Röschinger W; Becker M; Durner J; Eggermann K; Müller C; Hannibal I; Olgemöller B; Schara U; Blaschek A; Kölbel H
    J Neuromuscul Dis; 2020; 7(2):109-117. PubMed ID: 32144995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn Screening for Spinal Muscular Atrophy: A 2.5-Year Experience in Hyogo Prefecture, Japan.
    Sonehara S; Bo R; Nambu Y; Iketani K; Lee T; Shimomura H; Ueda M; Takeshima Y; Iijima K; Nozu K; Nishio H; Awano H
    Genes (Basel); 2023 Dec; 14(12):. PubMed ID: 38137033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PCR-Based Screening of Spinal Muscular Atrophy for Newborn Infants in Hyogo Prefecture, Japan.
    Noguchi Y; Bo R; Nishio H; Matsumoto H; Matsui K; Yano Y; Sugawara M; Ueda G; Wijaya YOS; Niba ETE; Shinohara M; Bouike Y; Takeuchi A; Okamoto K; Saito T; Shimomura H; Lee T; Takeshima Y; Iijima K; Nozu K; Awano H
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Postnatal management of preterm infants with spinal muscular atrophy: experience from German newborn screening.
    Trollmann R; Johannsen J; Vill K; Köhler C; Hahn A; Illsinger S; Pechmann A; Hagen MV; Müller-Felber W
    Orphanet J Rare Dis; 2024 Sep; 19(1):353. PubMed ID: 39327607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implementation of population-based newborn screening reveals low incidence of spinal muscular atrophy.
    Kay DM; Stevens CF; Parker A; Saavedra-Matiz CA; Sack V; Chung WK; Chiriboga CA; Engelstad K; Laureta E; Farooq O; Ciafaloni E; Lee BH; Malek S; Treidler S; Anziska Y; Delfiner L; Sakonju A; Caggana M
    Genet Med; 2020 Aug; 22(8):1296-1302. PubMed ID: 32418989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newborn Screening for Spinal Muscular Atrophy: DNA Preparation from Dried Blood Spot and DNA Polymerase Selection in PCR.
    Takeuchi A; Tode C; Nishino M; Wijaya YOS; Niba ETE; Awano H; Takeshima Y; Saito T; Saito K; Lai PS; Bouike Y; Nishio H; Shinohara M
    Kobe J Med Sci; 2019 Nov; 65(3):E95-E99. PubMed ID: 32029694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Newborn screening for spinal muscular atrophy in Germany: clinical results after 2 years.
    Vill K; Schwartz O; Blaschek A; Gläser D; Nennstiel U; Wirth B; Burggraf S; Röschinger W; Becker M; Czibere L; Durner J; Eggermann K; Olgemöller B; Harms E; Schara U; Kölbel H; Müller-Felber W
    Orphanet J Rare Dis; 2021 Mar; 16(1):153. PubMed ID: 33789695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dried Blood Spot Screening System for Spinal Muscular Atrophy with Allele-Specific Polymerase Chain Reaction and Melting Peak Analysis.
    Wijaya YOS; Nishio H; Niba ETE; Shiroshita T; Kato M; Bouike Y; Tode C; Ar Rochmah M; Harahap NIF; Nurputra DK; Okamoto K; Saito T; Takeuchi A; Lai PS; Yamaguchi S; Shinohara M
    Genet Test Mol Biomarkers; 2021 Apr; 25(4):293-301. PubMed ID: 33877896
    [No Abstract]   [Full Text] [Related]  

  • 15. Newborn screening for spinal muscular atrophy: The Wisconsin first year experience.
    Baker MW; Mochal ST; Dawe SJ; Wiberley-Bradford AE; Cogley MF; Zeitler BR; Piro ZD; Harmelink MM; Kwon JM
    Neuromuscul Disord; 2022 Feb; 32(2):135-141. PubMed ID: 35120759
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New multiplex real-time PCR approach to detect gene mutations for spinal muscular atrophy.
    Liu Z; Zhang P; He X; Liu S; Tang S; Zhang R; Wang X; Tan J; Peng B; Jiang L; Hong S; Zou L
    BMC Neurol; 2016 Aug; 16(1):141. PubMed ID: 27534852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiplex Droplet Digital PCR Method Applicable to Newborn Screening, Carrier Status, and Assessment of Spinal Muscular Atrophy.
    Vidal-Folch N; Gavrilov D; Raymond K; Rinaldo P; Tortorelli S; Matern D; Oglesbee D
    Clin Chem; 2018 Dec; 64(12):1753-1761. PubMed ID: 30352867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-throughput genetic newborn screening for spinal muscular atrophy by rapid nucleic acid extraction from dried blood spots and 384-well qPCR.
    Czibere L; Burggraf S; Fleige T; Glück B; Keitel LM; Landt O; Durner J; Röschinger W; Hohenfellner K; Wirth B; Müller-Felber W; Vill K; Becker M
    Eur J Hum Genet; 2020 Jan; 28(1):23-30. PubMed ID: 31363188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Newborn Screening for Spinal Muscular Atrophy: Ontario Testing and Follow-up Recommendations.
    McMillan HJ; Kernohan KD; Yeh E; Amburgey K; Boyd J; Campbell C; Dowling JJ; Gonorazky H; Marcadier J; Tarnopolsky MA; Vajsar J; MacKenzie A; Chakraborty P
    Can J Neurol Sci; 2021 Jul; 48(4):504-511. PubMed ID: 33059774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Newborn blood spot screening test using multiplexed real-time PCR to simultaneously screen for spinal muscular atrophy and severe combined immunodeficiency.
    Taylor JL; Lee FK; Yazdanpanah GK; Staropoli JF; Liu M; Carulli JP; Sun C; Dobrowolski SF; Hannon WH; Vogt RF
    Clin Chem; 2015 Feb; 61(2):412-9. PubMed ID: 25502182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.